118 related articles for article (PubMed ID: 38940590)
1.
Khan H; Bhargava V; Elkins KL
Microbiol Spectr; 2024 Jun; ():e0002824. PubMed ID: 38940590
[TBL] [Abstract][Full Text] [Related]
2. Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).
De Pascalis R; Chou AY; Ryden P; Kennett NJ; Sjöstedt A; Elkins KL
mBio; 2014 Apr; 5(2):e00936. PubMed ID: 24713322
[TBL] [Abstract][Full Text] [Related]
3. An
Golovliov I; Lindgren H; Eneslätt K; Conlan W; Mosnier A; Henry T; Sjöstedt A
Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
[No Abstract] [Full Text] [Related]
4. A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis.
De Pascalis R; Hahn A; Brook HM; Ryden P; Donart N; Mittereder L; Frey B; Wu TH; Elkins KL
PLoS One; 2018; 13(5):e0198140. PubMed ID: 29799870
[TBL] [Abstract][Full Text] [Related]
5. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
Kieffer TL; Cowley S; Nano FE; Elkins KL
Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
[TBL] [Abstract][Full Text] [Related]
6. Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages.
Bradford MK; Elkins KL
Sci Rep; 2020 Jul; 10(1):12023. PubMed ID: 32694562
[TBL] [Abstract][Full Text] [Related]
7. Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication.
Collazo CM; Sher A; Meierovics AI; Elkins KL
Microbes Infect; 2006 Mar; 8(3):779-90. PubMed ID: 16513388
[TBL] [Abstract][Full Text] [Related]
8. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
[TBL] [Abstract][Full Text] [Related]
9. Guanylate-Binding Proteins Are Critical for Effective Control of
Mohammadi N; Lindgren H; Golovliov I; Eneslätt K; Yamamoto M; Martin A; Henry T; Sjöstedt A
Front Cell Infect Microbiol; 2020; 10():594063. PubMed ID: 33363054
[No Abstract] [Full Text] [Related]
10. T-bet regulates immunity to Francisella tularensis live vaccine strain infection, particularly in lungs.
Melillo AA; Foreman O; Bosio CM; Elkins KL
Infect Immun; 2014 Apr; 82(4):1477-90. PubMed ID: 24421047
[TBL] [Abstract][Full Text] [Related]
11. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
[TBL] [Abstract][Full Text] [Related]
12. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
[No Abstract] [Full Text] [Related]
13. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
[TBL] [Abstract][Full Text] [Related]
14. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
[TBL] [Abstract][Full Text] [Related]
15. rM-CSF efficiently replaces L929 in generating mouse and rat bone marrow-derived macrophages for in vitro functional studies of immunity to intracellular bacteria.
Rice HM; Rossi AP; Bradford MK; Elkins KL; De Pascalis R
J Immunol Methods; 2020 Feb; 477():112693. PubMed ID: 31689421
[TBL] [Abstract][Full Text] [Related]
16. Macrophages Demonstrate Guanylate-Binding Protein-Dependent and Bacterial Strain-Dependent Responses to
Mohammadi N; Lindgren H; Yamamoto M; Martin A; Henry T; Sjöstedt A
Front Cell Infect Microbiol; 2021; 11():784101. PubMed ID: 35004352
[No Abstract] [Full Text] [Related]
17. Differential requirements by CD4+ and CD8+ T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth.
Cowley SC; Sedgwick JD; Elkins KL
J Immunol; 2007 Dec; 179(11):7709-19. PubMed ID: 18025217
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
Cole LE; Shirey KA; Barry E; Santiago A; Rallabhandi P; Elkins KL; Puche AC; Michalek SM; Vogel SN
Infect Immun; 2007 Aug; 75(8):4127-37. PubMed ID: 17517865
[TBL] [Abstract][Full Text] [Related]
19. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.
Cowley SC; Elkins KL
J Exp Med; 2003 Aug; 198(3):379-89. PubMed ID: 12885873
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Inner and Outer Membrane Proteins from
Post DMB; Slütter B; Schilling B; Chande AT; Rasmussen JA; Jones BD; D'Souza AK; Reinders LM; Harty JT; Gibson BW; Apicella MA
mBio; 2017 Oct; 8(5):. PubMed ID: 29018123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
